CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Shares Shorted: Short Interest Down 54.3% in October

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a large decline in short interest in October. As of October 15th, there was short interest totaling 1,339 shares, a decline of 54.3% from the September 30th total of 2,927 shares. Based on an average daily trading volume, of 4,208 shares, the short-interest ratio is presently 0.3 days.

CSPC Pharmaceutical Group Trading Down 4.2%

Shares of CSPCY traded down C$0.17 during mid-day trading on Friday, reaching C$3.94. 3,849 shares of the company’s stock were exchanged, compared to its average volume of 2,966. The company has a 50-day simple moving average of C$4.62 and a two-hundred day simple moving average of C$4.44. CSPC Pharmaceutical Group has a 52-week low of C$3.26 and a 52-week high of C$5.46.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. The company researches, develops, manufactures and distributes finished pharmaceutical products and active pharmaceutical ingredients, serving hospitals, pharmacies and other healthcare channels.

Its product portfolio includes medicines for neurological, cardiovascular, oncology, anti-infective and other therapeutic areas. CSPC is known for products such as butylphthalide, used in the treatment of ischemic stroke, as well as oncology medicines, injectable therapies and a range of generic drugs.